Position history for Alphabet Inc.'s holdings in BRIDGEBIO ONCOLOGY THERAPEUT
Alphabet Inc. holds 2.8M shares of BBOT (BRIDGEBIO ONCOLOGY THERAPEUT), worth $25.3M as of 2026-Q1. BBOT represents 0.6% of Alphabet Inc.'s portfolio.
Current Value
$25.3M
Current Shares
2.8M
Total Value Change
-$7.4M
Total Shares Change
0
Other major holders of BBOT: WELLINGTON MANAGEMENT GROUP LLP, CITADEL ADVISORS LLC, BlackRock, Inc.
Unchanged |
| 2.8M |
0.0% |
| $25.3M |
| 0.6% |
| $9.74 |
0 |
| 2025-Q4 | Unchanged | 2.8M | 0.0% | $35.3M | 1.4% | $12.37 | 0 |
| 2025-Q3 | New | 2.8M | - | $32.7M | 1.4% | $11.47 | 67 |